Global Solutions in Pulmonology, Immunology and Virology
Products
More
LIBI PHARM is a pioneering, privately owned Israeli drug and medical device development company that has created the patented, innovative product Virlaza®️, which could be a breakthrough in the treatment of a number of diseases characterized by acute respiratory failure, including those caused by the COVID-19 coronavirus, as well as a number of immunological disorders.
Reduces sickness days. Prevents and reduces irreversible tissue damage from the body's inflammatory response, including pulmonary fibrosis.
SMARTUBE
Device for processing blood samples containing a proprietary activation medium to stimulate antibody production (in-vitro)
Researches
Virlaza™ Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
Full text on medRxiv
Virlaza Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
Full text on The ScienceGate
A Case Report | Virlaza™ Improves Cardiopulmonary Recovery of Post-Covid-19 Patient
Full text on NCBI
Virlaza™ Improves Cardiopulmonary Recovery of Post-Covid-19 Patient: A Case Report
Full text on ChestJournal
Report: VIRLAZA TM in the Context of Lung Inflammation and Fibrosis in COVID-19
Full research
Hot News – Virlaza™ : inhibit cytokines release from airway epithelial cells in vitro
Full text on LABPEI
Hot News – Virlaza™ : improves pulmonary, hematological and muscular recovery of post-covid-19 patient
Full text on LABPEI
Our team
Boris Brill
Doctor
He is a Principal Clinical Investigator at Libi Pharm. Member of the Board of Trustees of the Kvitna Foundation, responsible for coordinating educational health charity programmes. Co-author of patentable drug inventions. Official at international and domestic MMA tournaments in Israel and grappling tournaments in Israel.
Dobroslav Melamed
Biotech scientist
Formerly President of Insight Biopharmaceutical, co-founder of Trioxbio LTD, Periness LTD, Oshadi LTD. He is a biotechnology entrepreneur with over 10 years of experience in the biotechnology industry. He was president of SciVac (formerly SciGen IL). Dr Melamed was a director of XTL Biopharmaceuticals Ltd. He holds a PhD in Biotechnology and a BSc in Biotechnology from Bar Ilan University, Israel.
Razi Ronen
Expert
Specialist in the research and production of preparations based on the chemical composition of herbal and mineral substances. Nutritionist, expert in the development and production of natural remedies for water purification, biological protection of crops and foodstuffs, as well as fully organic food supplements, body care products and pain relievers.
De Paula Vieira
Professor
He is a Principal Researcher at the Brazilian Institute of Training and Research in Pulmonary and Exercise Immunology. He holds a Bachelor's degree in Sports Science (Physical Education) (2001), a Master's degree in Biology (Physiology and Pharmacology) (2003) and a PhD in Pathology - Pulmonary Immunopathology (2007) from the Faculty of Medicine, University of São Paulo, Brazil (2007-2009).